Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).
about
Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11AThe pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertensionDapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculationNovel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).Phosphodiesterase type 5 and high altitude pulmonary hypertension.Sildenafil Prevents Apoptosis of Human First-Trimester Trophoblast Cells Exposed to Oxidative Stress: Possible Role for Nitric Oxide Activation of 3',5'-cyclic Guanosine Monophosphate SignalingAdenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarctionTargeting bladder outlet obstruction from benign prostatic enlargement via the nitric oxide/cGMP pathway?PDE5 inhibitors beyond erectile dysfunction.Phosphodiesterase-5 expression and function in the lower urinary tract: a critical review.Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy.Direct androgen regulation of PDE5 gene or the lack thereof.Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension.Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases.Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3)Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: sildenafil and papaverin generate inhibition.A novel access to arylated and heteroarylated beta-carboline based PDE5 inhibitors.Ectopic expression of bovine type 5 phosphodiesterase confers a renal phenotype in Drosophila.Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction.Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1.Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5.Isolation of two isoforms of phosphodiesterase 5 from rat penis.Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects.
P2860
Q24676441-21940A61-9A20-4DD1-AA3A-366DB9B2C9ABQ26852171-134CC6BD-79B3-4DC3-9738-D47D7361C178Q34589643-725F066F-BAF3-4A5A-BE4F-121579BA5E35Q35089850-DB73A241-16A8-454D-BDE8-B31A69E340D7Q35537900-6FAA4AB3-A166-478B-A314-82E08F3966A4Q35853161-DE3FF037-505D-4708-B6D9-2121A9C1CCE1Q35994136-E7254303-52E1-4AF3-B666-DA34E0C53F24Q36206614-B1C5EA39-10DA-4D8E-8ABB-663EDF76B360Q36878017-A4FEDE2C-B690-47AD-A881-7AC64E84A35EQ37340520-5E57889B-9F92-48EA-94C5-57A27545EB99Q37910906-47AEB7AF-3ABB-42E2-8974-13F3894B7445Q38088930-CFE3A07A-8846-4D02-8E09-E20A4467EB8BQ38126803-BE66923E-9DE5-4EF6-AA2F-E8373AA9F993Q38205932-35E2D464-102C-4CEA-A24F-7BF4E6EE768AQ39162731-3E3E0E16-C1FF-4520-9A78-BEDFBE82878EQ39503219-D6E2EB30-8023-49E8-A5C8-04D1FFF67A7DQ40373695-B1A67757-A181-4F2C-8B36-1E854084A572Q40650047-6A38F6A7-E24D-4337-BAB0-0AE679F850EFQ41839429-B9D61257-568F-4611-A01D-03334BED48AEQ42453932-4635EA25-B5A5-4D92-BC28-5CF03165032EQ42492175-5FF55BAC-A455-4188-B9BE-D4E67CFBA225Q42830730-1FEA41ED-A135-42AF-8717-233B4908474FQ44371553-3F9D36C3-9AB8-42CF-B0D6-3D8EC170A26DQ44467347-19E15A10-14B4-42CF-B05D-A03EBB7E5CF7Q45305137-F2315EDD-F24D-402C-9F1C-14F75F1C4F61Q46023200-03F07CCF-F677-4CB2-85CF-CB9AB0000CF5Q46427835-51C4BED6-DA51-4A52-BE16-78EA449145F6Q47945962-A064ED41-B5E3-4B79-9F4D-63C1C1C05C21Q51912004-C1A62B71-8CE8-464C-93C6-202428C3287D
P2860
Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Molecular cloning and expressi ...... ific phosphodiesterase (PDE5).
@en
type
label
Molecular cloning and expressi ...... ific phosphodiesterase (PDE5).
@en
prefLabel
Molecular cloning and expressi ...... ific phosphodiesterase (PDE5).
@en
P2093
P356
P1476
Molecular cloning and expressi ...... ific phosphodiesterase (PDE5).
@en
P2093
P304
P356
10.1006/BBRC.1998.8769
P407
P577
1998-06-01T00:00:00Z